News Focus
News Focus
Followers 64
Posts 11870
Boards Moderated 0
Alias Born 07/16/2006

Re: DewDiligence post# 10737

Sunday, 08/04/2013 6:37:47 PM

Sunday, August 04, 2013 6:37:47 PM

Post# of 20689

I think there’s a 72% probability that the FDA approves MNTA’s Copaxone ANDA before Teva’s patents expire in May 2014.



Considering that you thought there was a greater than 90% probability that the CERT would be granted and a 80% chance USSC takes the case doesn't bode well here.